Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer

INTRODUCTION: Testosterone suppression, or androgen-deprivation therapy (ADT), is an established treatment for recurrent and metastatic prostate cancer (PCa). Based on the accuracy and sensitivity of early assays (c. 1960–1970), the castrate testosterone level was set at ≤1.7 nmol/l. Improved sensit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Can Urol Assoc J
Prif Awduron: Klotz, Laurence, Breau, Rodney H., Collins, Loretta L., Gleave, Martin E., Pickles, Tom, Pouliot, Frederic, Saad, Fred
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Canadian Medical Association 2017
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403681/
https://ncbi.nlm.nih.gov/pubmed/28443139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4303
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg